Theralase Technologies Inc (TLT):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Theralase Technologies Inc (TLT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7491
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Theralase Technologies Inc (Theralase Technologies) is a biopharmaceutical company that manufactures, designs, and develops laser and laser technology for companion animal, human, and equine applications. The company offers products such as multiple probe, controller, multiple probe, triple probe, single probe, stand, acu-point locator, and laser safety eyewear products. It also provides laser probe, laser safety eye cups, hard carrying case, and protective covers, among others. Theralase Technologies’ lasers products find application in treating acute and chronic pain conditions, addictions and cosmetic revitalization. The company sells its products through a network of distributors in Canada, the US and internationally. Theralase Technologies is headquartered in Toronto, Ontario, Canada.

Theralase Technologies Inc (TLT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Theralase Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Theralase Technologies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Theralase Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Theralase Technologies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Theralase Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Theralase Technologies Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Theralase Technologies Raises USD0.84 Million in Non-Brokered Private Placement of Units 10
Theralase Technologies Raises USD0.8 Million in Private Placement of Units 11
Theralase Technologies Raises USD3.2 Million in Public Offering of Units 12
Theralase Technologies Completes Private Placement Of Units For US$3 Million 13
Theralase Technologies Completes Private Placement Of Units For Up To US$0.5 Million 14
Theralase Technologies Completes Private Placement Of Units For US$0.8 Million 15
Theralase Technologies Inc – Key Competitors 16
Theralase Technologies Inc – Key Employees 17
Theralase Technologies Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Jul 26, 2018: Theralase Released 2Q2018 Financial Statements 19
May 30, 2018: Theralase Increases Revenue 22% for 2017 Financial Statements 21
Nov 29, 2017: Theralase Increases Revenue 12% for 3Q2017 Financial Statements 23
Aug 29, 2017: Theralase Increases Revenue 14% for 2Q2017 Financial Statements 26
May 30, 2017: Theralase Increases Revenue 23% for 1Q 2017 Financial Statements 27
Product News 30
Jun 22, 2018: Theralase Strengthens Its Patent Portfolio with an Additional US Patent Covering Metal-Glycoprotein Complexes, Including Rutherrin(R) Based Photo Dynamic Therapy, in Immune Privileged Sites 30
Nov 30, 2017: Theralase Discovers Theralase Cold Laser Therapy Enhances Cancer Destruction for Standard Cancer Treatments 31
Other Significant Developments 34
Jun 28, 2018: Theralase Researchers Receive Government Grant 34
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Theralase Technologies Inc, Medical Equipment, Key Facts, 2017 2
Theralase Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Theralase Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Theralase Technologies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Theralase Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Theralase Technologies Inc, Deals By Market, 2012 to YTD 2018 8
Theralase Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Theralase Technologies Raises USD0.84 Million in Non-Brokered Private Placement of Units 10
Theralase Technologies Raises USD0.8 Million in Private Placement of Units 11
Theralase Technologies Raises USD3.2 Million in Public Offering of Units 12
Theralase Technologies Completes Private Placement Of Units For US$3 Million 13
Theralase Technologies Completes Private Placement Of Units For Up To US$0.5 Million 14
Theralase Technologies Completes Private Placement Of Units For US$0.8 Million 15
Theralase Technologies Inc, Key Competitors 16
Theralase Technologies Inc, Key Employees 17
Theralase Technologies Inc, Subsidiaries 18

List of Figures
Theralase Technologies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Theralase Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Theralase Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Theralase Technologies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Theralase Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Theralase Technologies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Theralase Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Theralase Technologies Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Theralase Technologies Inc (TLT):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hidd Power Company:企業の戦略的SWOT分析
    Hidd Power Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Phenex Pharmaceuticals AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Phenex Pharmaceuticals AG (Phenex Pharmaceuticals) is a drug discovery and development company that offers nuclear receptors for the development of novel therapies. The company offer services such as NR selectivity screening, contract screening services, and SNuRM profiling to pharmaceutical …
  • WestRock Co:戦略・SWOT・企業財務分析
    WestRock Co - Strategy, SWOT and Corporate Finance Report Summary WestRock Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • PetVivo Holdings Inc (PETV):企業の製品パイプライン分析2018
    Summary PetVivo Holdings Inc (PetVivo Holdings), formerly Technologies Scan Corp, is a biomedical device company. The company offers licensing and commercialization of medical devices and therapeutics to treat pets and animals suffering from arthritis and other afflictions. Its products include Kush …
  • Jyoti Structures Ltd (JYOTISTRUC):企業の財務・戦略的SWOT分析
    Jyoti Structures Ltd (JYOTISTRUC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Antares Pharma Inc (ATRS):企業の財務・戦略的SWOT分析
    Antares Pharma Inc (ATRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Bayer CropScience AG:企業のM&A・事業提携・投資動向
    Bayer CropScience AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bayer CropScience AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Mahle GmbH:企業の戦略的SWOT分析
    Mahle GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • The Michaels Companies, Inc.:企業の戦略・SWOT・財務情報
    The Michaels Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Michaels Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • EyeGate Pharmaceuticals Inc (EYEG)-医療機器分野:企業M&A・提携分析
    Summary EyeGate Pharmaceuticals Inc (EyeGate) is a clinical-stage specialty pharmaceutical company that offers eye care medicines. The company offers macular edema and non-infectious anterior uveitis. It offers technologies for most prevalent issues in ophthalmic care; the existing lack of patient a …
  • Methode Electronics Inc (MEI):企業の財務・戦略的SWOT分析
    Summary Methode Electronics Inc (Methode) is technology company. The company offers products such as user interface, lighting, sensors, medical devices, power distribution and digital data. Its user interface products include, guages, cameras, bell pushers, industrial remote controls, touch panels, …
  • Sharjah Electricity & Water Authority:企業の戦略的SWOT分析
    Sharjah Electricity & Water Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Talktalk Telecom Group PLC (TALK):企業の戦略的SWOT分析
    Talktalk Telecom Group PLC (TALK) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Imbed Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Imbed Biosciences Inc (Imbed) is a medical device company that develops technologies for imbedding bioactive molecules in wound dressings and surgical implants. The company’s polymeric microfilm product platform develops bioactive molecules on tissue surfaces to manage wound infections, biof …
  • Tempo Beverages Ltd.:企業の戦略・SWOT・財務分析
    Tempo Beverages Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tempo Beverages Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Insmed Inc (INSM):医療機器:M&Aディール及び事業提携情報
    Summary Insmed Inc (Insmed) is a biopharmaceutical company that focuses on rare diseases. Its lead product candidate, Arikayce (liposomal amikacin for inhalation), is indicated for the treatment of nontuberculous mycobacteria (NTM) lung disease in adult patients. Its other clinical pipeline are bein …
  • Kazanorgsintez (KZOS):企業の財務・戦略的SWOT分析
    Kazanorgsintez (KZOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Nevro Corp (NVRO):企業の財務・戦略的SWOT分析
    Summary Nevro Corp (Nevro) is a medical device company which focuses on providing novel products that advance the quality of life of people suffering from chronic pain. The company has developed Nevro Senza spinal cord stimulation (SCS) system, a non-pharmacologic neuromodulation platform for the tr …
  • Eris Lifesciences Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Eris Lifesciences Ltd (Eris Lifesciences) is a pharmaceutical company that manufactures and commercializes generics products. The company through its divisions provides wide range of products including Maxum, Decal, Eritel H, Eritel CH 80 LS, Glimisave Max Forte 1, Mac Rabonik Plus, Vomisave …
  • Koninklijke Vopak NV (VPK):石油・ガス:M&Aディール及び事業提携情報
    Summary Koninklijke Vopak NV (Vopak) is an independent tank storage company that stores and handles liquid oil products, chemicals, vegetable oils, biofuels and liquefied natural gases. It also offers logistics services, handles customs formalities and documentation for its customers at its terminal …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆